American Journal of Kidney Diseases
Volume 54, Issue 1 , Pages 59-69 , July 2009

Baseline Characteristics in the Trial to Reduce Cardiovascular Events With Aranesp Therapy (TREAT)

Received 25 February 2009 ,Accepted 10 April 2009.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 30.00 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

 A list of author affiliations appears at the end of this article.

 Originally published online as doi:10.1053/j.ajkd.2009.04.008 on June 8, 2009.

 Because an author of this manuscript is an editor for AJKD, the peer-review and decision-making processes were handled entirely by an Associate Editor (Peter McCullough, MD, MPH, William Beaumont Hospital) who served as Acting Editor-in-Chief. Details of the journal's procedures for potential editor conflicts are given in the Editorial Policies section of the AJKD website.

 A list of the TREAT Investigators is provided as online supplementary material for this article.

 Trial Registration: www.clinicaltrials.gov; study number: NCT00093015.

PII: S0272-6386(09)00640-4

doi: 10.1053/j.ajkd.2009.04.008

American Journal of Kidney Diseases
Volume 54, Issue 1 , Pages 59-69 , July 2009

Article Tools